CLGN
CollPlant Biotechnologies LtdCompany with tickers: CLGN
CIK
1631487
CUSIP
M2R51X116
Shares Outstanding
14,415,128
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-19 | Tal Yehiel | Director, Chief Executive Officer | Other | 31,137 |
| 2026-03-19 | Tal Yehiel | Director, Chief Executive Officer | Other | 0 |
| 2026-03-19 | Tal Yehiel | Director, Chief Executive Officer | Other | 80,000 |
| 2026-03-19 | Tal Yehiel | Director, Chief Executive Officer | Other | 0 |
| 2026-03-19 | Tal Yehiel | Director, Chief Executive Officer | Other | 0 |
| 2026-03-19 | Tal Yehiel | Director, Chief Executive Officer | Other | 0 |
| 2026-03-18 | Rotem Eran | Deputy CEO and CFO | Other | 0 |
| 2026-03-18 | Rotem Eran | Deputy CEO and CFO | Other | 0 |
| 2026-03-18 | Rotem Eran | Deputy CEO and CFO | Other | 0 |
| 2026-03-18 | Rotem Eran | Deputy CEO and CFO | Other | 60,000 |
| 2026-03-18 | Bensimon Philippe | VP Regulations and QA | Other | 0 |
| 2026-03-18 | Bensimon Philippe | VP Regulations and QA | Other | 0 |
| 2026-03-18 | Bensimon Philippe | VP Regulations and QA | Other | 2,000 |
| 2026-03-18 | Bensimon Philippe | VP Regulations and QA | Other | 0 |
| 2026-03-18 | Bensimon Philippe | VP Regulations and QA | Other | 0 |
| 2026-03-18 | Bensimon Philippe | VP Regulations and QA | Other | 30,000 |
| 2026-03-18 | Seror Jasmine | VP Product Development | Other | 0 |
| 2026-03-18 | Seror Jasmine | VP Product Development | Other | 12,000 |
| 2026-03-18 | Seror Jasmine | VP Product Development | Other | 0 |
| 2026-03-18 | Seror Jasmine | VP Product Development | Other | 0 |
| 2026-03-18 | Seror Jasmine | VP Product Development | Other | 0 |
| 2026-03-18 | Seror Jasmine | VP Product Development | Other | 0 |
| 2026-03-18 | Seror Jasmine | VP Product Development | Other | 45,000 |
| 2026-03-18 | Havron Avraham | Director | Other | 10,000 |
| 2026-03-18 | Havron Avraham | Director | Other | 0 |
| 2026-03-18 | Havron Avraham | Director | Other | 0 |
| 2026-03-18 | Havron Avraham | Director | Other | 0 |
| 2026-03-18 | Penn Elan | Director | Other | 0 |
| 2026-03-18 | Penn Elan | Director | Other | 0 |
| 2026-03-18 | Penn Elan | Director | Other | 0 |
| 2026-03-18 | Penn Elan | Director | Other | 7,500 |
| 2026-03-18 | Lask Alisa | Director | Other | 0 |
| 2026-03-18 | Lask Alisa | Director | Other | 10,000 |
| 2026-03-18 | Rotem Eran | Deputy CEO and CFO | Other | 0 |
| 2026-03-18 | Fahimipoor Oren | VP Operations | Other | 30,000 |
| 2026-03-18 | Fahimipoor Oren | VP Operations | Other | 0 |
| 2026-03-18 | Abelis Bar Berta | VP Legal | Other | 40,000 |
| 2026-03-18 | Abelis Bar Berta | VP Legal | Other | 0 |
| 2026-03-18 | Abelis Bar Berta | VP Legal | Other | 13,000 |
| 2026-03-18 | Bagley Bowman | VP Commercial North America | Other | 25,000 |
| 2026-03-18 | Evans Hugh M | Director | Other | 0 |
| 2026-03-18 | Evans Hugh M | Director | Other | 10,000 |
| 2026-03-18 | Evans Hugh M | Director | Other | 10,000 |
| 2026-03-18 | Evans Hugh M | Director | Other | 315,554 |
| 2026-03-18 | Evans Hugh M | Director | Other | 0 |
| 2026-03-18 | Evans Hugh M | Director | Other | 15,000 |